
Johnson & Johnson ordered to pay $40 million over talcum powder cancer claims
A Los Angeles jury awarded $40 million to two women claiming Johnson & Johnson's talcum powder caused their ovarian cancer, amid ongoing legal battles over the safety of talc in their products. Johnson & Johnson plans to appeal the verdict, which follows other recent large settlements related to talc and cancer claims.










